Saltar al contenido
Merck

Saltar a

C8261

Sodium chenodeoxycholate

≥97%

Sinónimos:

3α,7α-Dihydroxy-5β-cholanic acid, 5β-Cholanic acid-3α,7α-diol, Chenodeoxycholic acid sodium salt, Chenodesoxycholic acid, Chenodiol

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
Tamaño de envaseSKUDisponibilidadPrecio

Acerca de este artículo

Fórmula empírica (notación de Hill):
C24H39NaO4
Número CAS:
Peso molecular:
414.55
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12161900
MDL number:
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


description

anionic

Quality Segment

assay

≥97%

form

powder

mol wt

414.55 g/mol

technique(s)

protein purification: suitable

SMILES string

[Na].[H][C@@]12C[C@H](O)CC[C@]1(C)[C@@]3([H])CC[C@]4(C)[C@]([H])(CC[C@@]4([H])[C@]3([H])[C@H](O)C2)[C@H](C)CCC(O)=O

InChI

1S/C24H40O4.Na.H/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26;;/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28);;/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-;;/m1../s1

InChI key

WANBNZVOEKGHSS-VQNKLXGESA-N

General description

Sodium chenodeoxycholate is a bile salt, which has been shown to accelerate colonic transit and improve bowel function. [1]

Application

Sodium chenodeoxycholate has been used in a study to assess DNA repair response in the bacterium Escherichia coli. [2] It has also been used in a study to investigate the physical and chemical factors influencing germination of Clostridium difficile spores. [3]

Biochem/physiol Actions

Bile Salt

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
30970C644527029
form

powder

form

powder

form

powder

form

powder

assay

≥97%

assay

≥98.0% (dry matter, NT)

assay

≥99%

assay

≥97.0% (dried material, NT)

technique(s)

protein purification: suitable

technique(s)

DNA purification: suitable, RNA purification: suitable, electrophoresis: suitable

technique(s)

-

technique(s)

-

Quality Level

200

Quality Level

300

Quality Level

200

Quality Level

200

description

anionic

description

anionic

description

anionic

description

anionic

mol wt

414.55 g/mol

mol wt

micellar avg mol wt 1200-5000

mol wt

micellar avg mol wt 900-1300

mol wt

micellar avg mol wt 900-1300


pictograms

Skull and crossbonesHealth hazard

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Repr. 2

Clase de almacenamiento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos


Artículos

Probiotics exhibit an inhibitory effect on pathogens, help prevent chronic intestinal inflammatory diseases or atopic syndromes, and support the immune system.


L J Wheeldon et al.
Journal of applied microbiology, 105(6), 2223-2230 (2009-01-06)
To investigate the influence of chemical and physical factors on the rate and extent of germination of Clostridium difficile spores. Germination of C. difficile spores following exposure to chemical and physical germinants was measured by loss of either heat or
V Vanhoorne et al.
Orphanet journal of rare diseases, 14(1), 186-186 (2019-08-03)
Pharmaceutical compounding of orphan active ingredients can offer cost-effective treatment to patients when no other drug product is available for a rare disease or during periods of drug product shortages. Additionally, it allows customized therapy for patients with rare diseases.
Tina Kauss et al.
Journal of pharmaceutical sciences, 108(8), 2805-2813 (2019-03-18)
Current pediatric antibiotic therapies often use oral and parenteral routes of administration. Neither are suitable for treating very sick neonates who cannot take oral medication and may be several hours away from hospital in developing countries. Here, we report on



Número de artículo de comercio global

SKUGTIN
C8261-500MG04061833619117
C8261-1G04061833521984

Questions

Reviews

No rating value

Active Filters